Efficacy of hyperthermic intraperitoneal chemotherapy and interval debulking surgery in women with advanced uterine serous carcinoma

• Egile Nagusiak: Laura M. Chambers (Egilea), Danielle Chau (Egilea), Meng Yao (Egilea), Anthony B. Costales (Egilea), Peter G. Rose (Egilea), Chad M. Michener (Egilea), Robert Debernardo (Egilea), Roberto Vargas (Egilea)
• Formatua: Liburua
• Argitaratua: Elsevier, 2021-11-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Objective(s): To investigate the efficacy and safety of hyperthermic intraperitoneal chemotherapy (HIPEC) at the time of iterval debulking surgery (IDS) in women with advanced uterine serous carcinoma (USC) following neoadjuvant chemotherapy (NACT). Methods: An IRB-approved single-institution prospe...